← Back to Clinical Trials
Recruiting NCT07463742

NCT07463742 Transcriptomic Profile Changes in Benign Tracheal Stenosis: Wedge Resection vs. Radial Incision

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07463742
Status Recruiting
Phase —
Sponsor University of Maryland, Baltimore
Condition Tracheal Stenosis
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-05-01
Primary Completion 2031-05-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Bronchoscopy, carbon dioxide (CO2) laser wedge resectionRadial incision with dilation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-05-01 with a primary completion date of 2031-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Some people develop a narrowing of their windpipe (trachea), called benign tracheal stenosis, which can make it hard to breathe. Doctors often treat this by using a bronchoscope-a thin, flexible tube with a camera-to open up the airway or remove scar tissue. While these procedures help patients breathe better, we do not fully understand why the narrowing occurs or how the tissue heals afterward. The purpose of this study is to better understand the biological changes in the airway tissue before and after these standard medical procedures. During the procedure, small samples of tissue that would already be collected as part of normal care will be analyzed in the laboratory. The results may help doctors learn more about airway healing and could guide better treatments in the future.

Eligibility Criteria

Inclusion Criteria: * symptomatic tracheal stenosis * idiopathic subglottic stenosis * iatrogenic tracheal stenosis from intubation or tracheostomy Exclusion Criteria: * positive ANA or ANCA * tracheal stenosis from infection, i.e. TB * tracheal stenosis with cartilage fracture * tracheal stenosis with malacia * tracheal stenosis from malignancy * tracheal stenosis from benign tumor * presence of glottic or supraglottic stenosis

Contact & Investigator

Central Contact

Chenchen Zhang, MD

✉ chenchen.zhang@som.umaryland.edu

📞 410-328-8138

Frequently Asked Questions

Who can join the NCT07463742 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Tracheal Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07463742 currently recruiting?

Yes, NCT07463742 is actively recruiting participants. Contact the research team at chenchen.zhang@som.umaryland.edu for enrollment information.

Where is the NCT07463742 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT07463742 clinical trial?

NCT07463742 is sponsored by University of Maryland, Baltimore. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology